Elizabeth Repasky is Lawrence J. Minet Professor of Immunology and program leader for the Cancer Stress Biology Program at Roswell Park Comprehensive Cancer Center. She graduated from Seton Hill University with a B.A. in biology, received her Ph.D. from the Buffalo State University and did a postdoctoral fellowship at the California Institute of Technology. Her research on thermal stress and the impact of thermoregulatory pathways on the anti-tumor immune response has been a long-standing passion. Repasky has been recognized as a distinguished biomedical alumna of the Jacobs School of Medicine and Biomedical Sciences at Buffalo State University. She is a recipient of the Dr. Thomas B. Tomasi Hope Award at Roswell Park and of both the J. Eugene Robinson and William C. Dewey Awards for her contributions to the field of thermal medicine.
Elizabeth Repasky
Professor of immunology
Roswell Park Comprehensive Cancer Center
From this contributor
Mouse housing temperatures can cook experimental outcomes
Selected articles
- “Baseline tumor growth and immune control in laboratory mice are significantly influenced by sub-thermoneutral housing temperature” | PNAS
- “Manipulation of ambient housing temperature to study the impact of chronic stress on immunity and cancer in mice” | Journal of Immunology
- “β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells” | Journal of Clinical Investigation
- “Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T Cells in the tumor microenvironment” | Cancer Immunology Research
- “How murine models of human disease and immunity are influenced by housing temperature and mild thermal stress” | Temperature
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.